C12Y 305/04003
Guanine deaminase
Official title: Guanine deaminase (3.5.4.3)
C12Y305/04003 (Guanine deaminase) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 12
- Inventors
- 30
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nucleobase editors and methods of use thereof16 Sep 2025US 12,416,001 B2Ohio State Innovation Foundation
- Selective advantage in fermentation13 Jun 2023US 11,674,162 B2Ginkgo Bioworks, Inc.
- Nucleosidase agent having reduced contaminant activity16 Aug 2022US 11,414,654 B2Amano Enzyme Inc.
- Process for the preparation of ammeline17 Mar 2020US 10,590,447 B2Dsm IP Assets B.V.
- Nucleobase editors and methods of use thereof12 Mar 2026US 2026/0071202 A1Ohio State Innovation Foundation
- Base editing-mediated readthrough of premature termination codons (bert)6 Nov 2025US 2025/0339559 A1President and Fellows of Harvard College
- Nucleobase editors and methods of use thereof13 Apr 2023US 2023/0116627 A1Ohio State Innovation Foundation
- Genetically engineered cyanobacteria for growth in unsterilized conditions using antibiotic-free selection3 Feb 2022US 2022/0033828 A1Nanyang Technological University
- Nucleosidase agent having reduced contaminant activity28 Jan 2021US 2021/0024911 A1Amano Enzyme Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.